Format

Send to

Choose Destination
Glob J Addict Rehabil Med. 2017 Feb;1(2). pii: 555556. doi: 10.19080/GJARM.2017.01.555556. Epub 2017 Feb 23.

Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD).

Author information

1
Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, USA.
2
Department of Psychiatry and Behavioral Sciences, Keck Medicine University of Southern California, USA.
3
Division of Applied Clinical Research & Education, Dominion Diagnostics, USA.
4
Department of Neurogenetics, Igene, USA.
5
National Institute for Holistic Addiction Studies, USA.
6
Department of Clinical Neurology, Path Foundation NY, USA.
7
Division of Neuroscience Based Addiction Therapy, The Shores Treatment & Recovery Center, USA.
8
Eötvös Loránd University, Institute of Psychology, Europe.
9
Department of Psychiatry, Wright State University Boonshoft School of Medicine and Dayton VA Medical Center, US.
10
Division of Reward Deficiency Syndrome, Nupathways, Inc., Innsbrook, MO, USA.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center